Overview

RCT Investigating Pre-cesarean Vaginal Wash of Chlorhexidine vs Povidone-iodine for Patient With Ruptured Amniotic Membrane.

Status:
Withdrawn
Trial end date:
2023-05-01
Target enrollment:
0
Participant gender:
Female
Summary
The objective of this study is to investigate if the rate of infectious morbidity is decreased with the use of chlorhexidine or povidone-iodine vaginal scrub before cesarean section after ruptured membranes.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Cadexomer iodine
Chlorhexidine
Chlorhexidine gluconate
Iodine
Pharmaceutical Solutions
Povidone
Povidone-Iodine
Criteria
Inclusion Criteria:

- Females aged 18-50 years

- The study will be offered to women at > 24 weeks gestation who are undergoing
nonemergent cesarean delivery with ruptured amniotic membranes.

- All patients undergoing cesarean delivery with ruptured amniotic membranes.

Exclusion Criteria:

- Minors

- Emergent cesarean delivery.

- No ruptured membranes.

- Allergy to chlorhexidine or povidone-iodine.